At a stalled replication fork, TLS depends on a handoff from the normal replication machinery to a specialized polymerase. The specialized enzyme inserts a nucleotide opposite the damaged base or across another distortion, creating a temporary route past the obstruction. Once the lesion has been bypassed, replication can continue, linking lesion bypass to completion of genome duplication.
The key distinction is fidelity. Replicative polymerases normally copy DNA accurately, whereas TLS polymerases are recruited specifically when damage blocks that process and can insert nucleotides with lower accuracy. This trade-off allows synthesis to proceed past a lesion, but it also means that restarting replication may leave behind a mutation, affecting later genome stability.
The outcome reflects a balance between successful lesion bypass and the lower accuracy associated with specialized polymerases. When the damaged region is traversed and synthesis resumes, the cell can complete genome duplication and survive the damage. If nucleotide insertion is inaccurate, the same tolerance process can convert a temporary replication problem into a lasting mutation.
Useful endpoints include whether replication resumes after a damaged template is encountered, whether genome duplication is completed, and whether cells survive the damage. Researchers also need to consider mutation formation and overall genome stability, because successful bypass can preserve viability while still increasing the risk of copying errors.
TLS connects DNA damage with two contrasting consequences: cells may tolerate lesions well enough to continue genome duplication, yet error-prone bypass may introduce mutations. Examining that relationship helps biology research interpret how damage responses influence genome stability and disease mechanisms, without treating survival after damage as evidence that the underlying DNA sequence remained unchanged.
Cancer research can view TLS as a potential point for targeting DNA-damage responses. Its activity supports replication and survival after damage, while its lower accuracy can contribute to mutations. Studying that balance may help researchers consider strategies that alter damage tolerance or mutagenesis in cancer, although this represents a potential strategy rather than a defined treatment.